A Phase III Randomized Study of Liposomal Doxorubicin Plus Carboplatin Versus Carboplatin in Platinum-Sensitive Patients With Recurrent Epithelial Ovarian and Peritoneal Carcinoma After Failure of Initial Platinum-Based Chemotherapy.
Phase of Trial: Phase III
Latest Information Update: 28 Oct 2015
At a glance
- Drugs Carboplatin; Doxorubicin liposomal
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 12 Jun 2012 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 12 Jun 2012 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History